General Aspects of *S. schenckii*
=================================

Sporotrichosis is a subcutaneous mycosis caused by the dimorphic fungus *Sporothrix schenckii*. This disease has several clinical forms and, until now, no clear scientific evidence can explain the occurrence of cutaneous disseminated and/or extracutaneous forms of sporotrichosis in immunocompetent patients (Lima Barros et al., [@B14]; Schubach et al., [@B34]). These clinical observations indicate that besides the immunological background of the host, other factors associated with the pathogen can impair the clinical manifestations of this disease, such as virulence factors (i.e., adhesins) and antigenic molecules. Some of these factors of *S. schenckii* will be briefly discussed in this review article, focusing on the fungus surface.

Another important feature that should be highlighted is the recent description of several genotypes indicating that *S. schenckii* is a complex of cryptic species, denominated the *S. schenckii* complex (Marimon et al., [@B20], [@B19]). Within this complex, at least five species are considered of interest due to their pathogenic potential (Arrillaga-Moncrieff et al., [@B2]). Among these, *S. globosa* have already been associated with human cases (Oliveira et al., [@B27]) and *S. brasiliensis* with feline sporotrichosis (Lopes-Bezerra L. M., unpublished results) in Brazil. The genome project of two pathogenic species, *S. schenckii* and *S. brasiliensis*, are currently under development (Felipe M. S. and Lopes-Bezerra L. M., personal communication) and will bring new insights regarding virulence factors and other relevant biological aspects of these two pathogenic species, which can be further associated with noteworthy clinical and epidemiological aspects of sporotrichosis.

Subcutaneous fungal infections are usually chronic conditions. They often begin after the skin has been pierced following an injury of some kind, since this allows infectious fungi to penetrate the skin and establish themselves inside the host. Eventually, a subcutaneous infection like sporotrichosis can evolve to severe systemic or disseminated forms. In this rather complicated puzzle, the first step for a pathogen to succeed is its capacity to adhere to and colonize host tissues. The binding of pathogen-associated molecular patterns (PAMPs) as cell wall sugar polymers and proteins, to pattern recognition receptors (PRRs) on innate immune cells triggers the activation of the immune system (Bourgeois et al., [@B4]; Latgé, [@B10]). Additionally, adhesion molecules expressed on the fungus cell surface can mediate their interaction with host cells and extracellular matrix components (Tronchin et al., [@B38]).

One of the well known cell wall components of *S. schenckii* is the peptidorhamnomannan. This glycopeptide or glycoconjugate is a complex of molecules with a wide range of molecular weights that are hard to purify as individual components (Lima and Lopes-Bezerra, [@B13]). This cell wall peptidorhamnomannan fraction (CWPR) can be recognized by IgG antibodies present in patient sera (Lloyd and Bitoon, [@B15]; Penha and Lopes-Bezerra, [@B28]) and by host cell receptors and matricial proteins (Lima et al., [@B12]; Figueiredo et al., [@B7]). Another interesting cell wall component, also present in the fungus culture filtrate, is a 70-kDa antigen (Lima and Lopes-Bezerra, [@B13]; Nascimento and Almeida, [@B24]). Furthermore, several groups have reported evidence of the role of gp70 as an important adhesin that can mediate fungus adhesion to host tissues and to matricial proteins of the basal lamina (López-Romero et al., [@B18]).

Cell Wall Glycoconjugates
=========================

*Sporothrix schenckii* has two morphological phases: a mycelial saprophytic form and a parasitic yeast-like form. Alkali-soluble and -insoluble glucans were detected in both morphological phases of this fungus. Alkali-soluble glucans of the yeast form of *S. schenckii* are linked by β(1,3), β(1,6), and β(1,4) bonds at 44, 28, and 28%, respectively. Insoluble glucans contain 66, 29, and 5%, respectively, of β(1,3), β(1,6), and β(1,4) bonds. No variations in β-glucan composition were correlated with the fungus morphological transition (Previato et al., [@B30]). Furthermore, there is no evidence in the literature concerning the presence of an α-glucan on the fungus surface, similar to that described for other dimorphic fungi.

The cell wall peptidorhamnomannan is composed of 33.5% rhamnose, 57% mannose, and 14.2% protein and was characterized in the yeast-phase of *S. schenckii* (Lloyd and Bitoon, [@B15]). In addition to rhamnose and mannose, polysaccharides containing galactose have also been identified on the surface of this fungus. A similar component containing rhamnose and mannose was detected in a fraction isolated from the culture filtrate of *S. schenckii* (Ishizaki, [@B9]). This culture filtrate glycopeptide was also shown to be antigenic and its antigenicity varied according to the rhamnose:mannose molar ratio, which is influenced by the culture conditions (Takata and Ishizaki, [@B35]).

Another intriguing finding was the observation that *S. schenckii* peptidorhamnomannans reacted with the carbohydrate-binding protein Concanavalin A (lectin ConA), but the rhamnomannans extracted by hot alkali treatment was non-reactive (Travassos et al., [@B37]). These findings did not confirm the preliminary structural evidence indicating the presence of mannose residues at non-reducing ends of the carbohydrate moiety of peptidorhamnomannan (Lloyd and Bitoon, [@B15]). Further biochemical studies verified that ConA reactivity was associated with the presence of *O*-glycosidically linked chains in the CWPR structure (Lopes-Alves et al., [@B16]). The *O*-linked oligosaccharides had a common internal core of α-[d]{.smallcaps}-Man 1 → 2 α-[d]{.smallcaps}-Man (illustrated in Figure [1](#F1){ref-type="fig"}) and the 2-*O* substituted mannose residue was identified as the lectin binding domain present on the fungus cell surface (Lopes-Alves et al., [@B16]). Immunocytochemical analysis of antigens in the outermost layer of yeast cells of *S. schenckii* revealed labeling of these antigens by polyclonal antibodies colocalized with regions reactive with ConA (Castillo et al., [@B5]).

![**(A,B)** Schematic representation showing the general structure of the main antigenic epitopes and ConA-binding sites described on the cell wall peptidorhamonomannan of both the yeast (Y) and mycelial (M) phases of *S. schenckii*.](fmicb-02-00243-g001){#F1}

The peptidorhamnomannan fraction described by Lloyd and Bitoon ([@B15]) reacted with sera from patients with sporotrichosis. The main carbohydrate epitopes identified in the *N*- and *O*-glycosidically linked chains of CWPR are illustrated in Figures [1](#F1){ref-type="fig"}A,B. In addition, an enriched glycopeptide cell wall fraction inhibited the adhesion of the yeast-phase of *S. schenckii* to extracellular matrix proteins, suggesting the presence of adhesins on the surface of this pathogen (Lima et al., [@B12], [@B11]). In addition to rhamnose and mannose, polysaccharides containing galactose have been identified on the surface of this fungus, suggesting the presence of a cell wall galactomannan (Mendonça et al., [@B21]; Mendonça-Previato et al., [@B22]). A peptidorhamnogalactan has previously been isolated from yeast-like cells (Nakamura, [@B23]). Glucuronic acid residues have been described in an acidic fraction of rhamnomannans from *S. schenckii* (Gorin et al., [@B8]). In addition, the *O*-glycosidic chains showed important antigen determinants involving α-[d]{.smallcaps}-glucuronic acid residues mono- and disubstituted by terminal non-reducing rhamnose residues (Figure [1](#F1){ref-type="fig"}A; Lopes-Alves et al., [@B17]).

Interestingly, a structurally similar cell surface peptidorhamnomannan was described in the pathogenic fungus *Pseudallescheria boydii* and, this peptidopolysaccharide also presented *O*-linked chains (Pinto et al., [@B29]). Similarly to *S. schenckii*, the rhamnose containing structures appear to be immunodominant epitopes.

*S. schenckii* Antigens
=======================

Antigens isolated from both the culture filtrate and the cell wall have been used for intradermal tests in guinea pigs and humans (Nielsen, [@B26]). Sporotrichin tests, however, have yielded false-positive results in individuals with no history of sporotrichosis (Schneidau et al., [@B33]). Furthermore, antigens isolated from the culture filtrate are highly heterogeneous (Takata and Ishizaki, [@B35]).

Since the cell wall is the surface structure of the fungal cell and therefore mediates the relation with the host, it represents an important source of antigens. Several studies have been conducted with the objective of isolating and identifying antigens on the cell wall of *S. schenckii*. The evidence that the *O*-linked tetra- and pentasaccharides carry important antigenic epitopes (Table [1](#T1){ref-type="table"}), α-[l]{.smallcaps}-Rha*p* 1 → 2 α-[d]{.smallcaps}-GLcA*p* and α-[l]{.smallcaps}-Rha*p* 1 → 4 α-[d]{.smallcaps}-GlcA*p* (Figure [1](#F1){ref-type="fig"}), which had not been described in other species, suggested that they could be used as potential markers for serodiagnosis (Lopes-Alves et al., [@B17]). Using the recognition and binding capacity of these CWPR *O*-glycosidic chains to the lectin ConA, Lima and Lopes-Bezerra ([@B13]) purified a cell wall ConA-binding fraction, called *Ss*CBF (*S. schenckii* *C*onA-*b*inding *f*raction). In ELISA assays using human sera (gold standard), this antigenic fraction was recognized by IgG antibodies present in the sera of patients with all clinical forms of sporotrichosis (Bernardes-Engemann et al., [@B3]) and this recognition was specifically blocked by the purified *O*-linked tetra- and pentasaccharides (Penha and Lopes-Bezerra, [@B28]). This serological test has also been useful for therapeutic follow-up of patients (Bernardes-Engemann et al., [@B3]). Another serological ELISA test was proposed in the literature (Almeida-Paes et al., [@B1]), based on a culture filtrate antigenic preparation. The ELISA tests described in the current literature showed values of specificity and sensibility ranging from 80 to 95%. Another recent study confirmed that the *Ss*CBF antigen could also be useful for the serodiagnosis of feline sporotrichosis (Fernandes et al., [@B6]).

###### 

**Maximum inhibition (%) of *S. schenckii* peptidorhamnomannan immunoprecipitation with its derived *O*-linked oligosaccharides (at 1 μmol)**.

  Oligosaccharide         \% Inhibition
  ----------------------- ---------------
  Trisaccharide           28
  Tetrasaccharide         63
  Pentasaccharide         82
  Tri + pentasaccharide   95

*Adapted from Lopes-Alves et al. ([@B17])*.

In conclusion, non-invasive diagnostic tools are available to promptly diagnose not only the classic lymphocutaneous or fixed cutaneous forms of sporotrichosis, but also the disseminated and atypical forms of this disease or unresolved cases that are negative according to the routine mycological test.

*S. schenckii* gp70
===================

In the cell wall *Ss*CBF antigenic fraction three main antigens with approximate molecular weights of 84 (gp84), 70 (gp70), and 58 kDa which reacted with a rabbit anti-*S. schenckii* serum were identified (Lima and Lopes-Bezerra, [@B13]). 2D-immunoblotting with anti-*S. schenckii* antibodies had shown that a 70-kDa glycoprotein was the major antigen detected in the cell wall of the mycelial and the yeast-like phases of *S. schenckii* and, a 60-kDa antigenic glycoprotein was present only on the surface of yeast-like cells (Ruiz-Baca et al., [@B31]).

Further studies had shown that sera from mice infected with *S. schenckii* had IgG1 and IgG3 antibodies reacting with a gp70 antigenic component present in the fungus culture filtrate (Nascimento and Almeida, [@B24]). A monoclonal antibody was raised against the secreted gp70 antigen, mAb P6E7. This monoclonal antibody had a protective effect *in vivo* by passive immunization of mice infected with *S. schenckii* (Nascimento et al., [@B25]). Besides, the secreted gp70 antigen was also shown to be expressed on the cell wall of the yeast-like phase of several clinical isolates of *S. schenckii* (Teixeira et al., [@B36]). This antigenic glycoprotein seems to have other important functions. There is strong evidence for its role as an adhesin which mediates *S. schenckii* interaction with the extracellular matrix protein fibronectin and also, adhesion of this fungus to the dermis of mouse tails (Ruiz-Baca et al., [@B32]; Teixeira et al., [@B36]). The co-localization on the yeast cell surface of a fibronectin adhesin and the mAb P6E7 antibody was confirmed by confocal microscopy, suggesting that the gp70 exoantigen and the cell wall protein with apparent MW of 70 kDa are similar components (Teixeira et al., [@B36]).

The purified gp70 exhibited a pI of 4.1 and about 5.7% of its molecular mass was contributed by *N*-linked glycans with no evidence for *O*-linked oligosaccharides (Ruiz-Baca et al., [@B32]).
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